Risk and Benefit of the Concomitant Use of Benzodiazepines and Opiates
dc.contributor.author | Angelini, Michael | |
dc.date | 2022-08-11T08:08:06.000 | |
dc.date.accessioned | 2022-08-23T15:42:35Z | |
dc.date.available | 2022-08-23T15:42:35Z | |
dc.date.issued | 2015-02-28 | |
dc.date.submitted | 2017-12-14 | |
dc.identifier.doi | 10.13028/dnsm-7f04 | |
dc.identifier.uri | http://hdl.handle.net/20.500.14038/26884 | |
dc.description.abstract | This presentation describes the possible benefits and risks associated with the concomitant use of opiate and benzodiazepine medications. Presented at the American Drug Utilization Review Society 2015 Conference. | |
dc.language.iso | en_US | |
dc.subject | opiates | |
dc.subject | benzodiazepines | |
dc.subject | behavioral health | |
dc.subject | opioid management | |
dc.subject | pharmacy | |
dc.subject | drug utilization review | |
dc.subject | Health Economics | |
dc.subject | Health Law and Policy | |
dc.subject | Health Policy | |
dc.subject | Health Services Administration | |
dc.subject | Health Services Research | |
dc.subject | Pharmacy and Pharmaceutical Sciences | |
dc.title | Risk and Benefit of the Concomitant Use of Benzodiazepines and Opiates | |
dc.type | Presentation | |
dc.identifier.legacyfulltext | https://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1124&context=commed_pubs&unstamped=1 | |
dc.identifier.legacycoverpage | https://escholarship.umassmed.edu/commed_pubs/120 | |
dc.identifier.contextkey | 11253740 | |
refterms.dateFOA | 2022-08-23T15:42:35Z | |
html.description.abstract | <p>This presentation describes the possible benefits and risks associated with the concomitant use of opiate and benzodiazepine medications.</p> <p>Presented at the American Drug Utilization Review Society 2015 Conference.</p> | |
dc.identifier.submissionpath | commed_pubs/120 | |
dc.contributor.department | Commonwealth Medicine, Clinical Pharmacy Services |